taurocholic acid has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brouwer, KL; Kemp, DC; Zamek-Gliszczynski, MJ | 1 |
| Chiou, SY; Lai, GW; Lin, G; Lin, LY | 1 |
2 other study(ies) available for taurocholic acid and cardiovascular agents
| Article | Year |
|---|---|
Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Topics: Animals; Bile Canaliculi; Bosentan; Cardiovascular Agents; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Drug Combinations; Hepatocytes; Male; Rats; Rats, Wistar; Sulfonamides; Taurocholic Acid; Thiazolidinediones; Troglitazone | 2005 |
Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro.
Topics: Amlodipine; Cardiovascular Agents; Enzyme Inhibitors; Hydralazine; Kinetics; Nifedipine; Octoxynol; Simvastatin; Sterol Esterase; Taurocholic Acid | 2006 |